This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Designing an IHC experiment for MICAL2? The guide has the expected staining pattern, antigen retrieval and fixation, antibodies backed by real IHC images, the tissue controls to run alongside, and protocols taken from published papers.
Open the MICAL2 IHC Guide1 Citations
Facts about [F-actin]-monooxygenase MICAL2.
Acts as a key regulator of the SRF signaling pathway elicited by nerve growth factor and serum: mediates oxidation and subsequent depolymerization of nuclear actin, resulting in increase MKL1/MRTF-A existence in the nucleus and encourage SRF:MKL1/MRTF-A-dependent gene transcription. Doesn't activate SRF:MKL1/MRTF-A through RhoA (PubMed:24440334).
| Human | |
|---|---|
| Gene Name: | MICAL2 |
| Uniprot: | O94851 |
| Entrez: | 9645 |

| Belongs to: |
|---|
| Mical family |

DKFZp686H03148; DKFZp686H2469; flavoprotein oxidoreductase MICAL2; KIAA0750MICAL2PV2; MICAL2PV1; microtubule associated monoxygenase, calponin and LIM domain containing 2; protein MICAL-2
Mass (kDA):
126.689 kDA

| Human | |
|---|---|
| Location: | 11p15.3 |
| Sequence: | 11; NC_000011.10 (12110576..12263790) |
Nucleus.




PMID: 16675569 by Ashida S., et al. Expression of novel molecules, MICAL2-PV (MICAL2 prostate cancer variants), increases with high Gleason score and prostate cancer progression.
PMID: 12110185 by Terman J.R., et al. MICALs, a family of conserved flavoprotein oxidoreductases, function in plexin-mediated axonal repulsion.